The largest database of trusted experimental protocols

8 protocols using 3130 automated sequencer

1

Genetic Analysis of SCN4A Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from blood samples using FlexiGene DNA Kit (Qiagen, Hilden, Germany). DM1 and DM2 expansion and CLCN1 mutations were excluded in the probands of each family. PCR fragments containing all the 24 coding exons and intron–exon junctions of SCN4A were amplified (primer sequences and conditions are available upon request). The fragments were directly sequenced using the same PCR primers and Big Dye Terminator Cycle Sequencing Kit in an automated sequencer 3130 (Applied Biosystems, Foster City, USA). Sequences were aligned using SeqScape software (Applied Biosystems) and compared to sequences NG_011699 and NM_000334 from NCBI. To confirm the results obtained, amplification and sequencing were repeated and the novel variant was checked in 200 Italian controls.
Microsatellite markers analysis was performed in order to verify the hypothesis of a founder effect for the c.644T>C mutation. Families 1, 2, and 3 were genotyped using markers D17S787, D17S944, D17S949, and D17S785 from ABI PRISM Linkage Mapping Set v2.5 (panels 23 and 24; Applied Biosystems) and markers D17S1792, D17S113, D17S584, D17S789, and D17S1786 annotated in NCBI (amplification conditions are available upon request). The fragments were resolved in an automated sequencer 3130 and the results were analyzed with GeneMapper Software 5 (Applied Biosystems).
+ Open protocol
+ Expand
2

TOSV Detection by Sequencing and Phylogenetic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Specific TOSV detection was carried out by sequencing PCR products as described previously [24 (link)]. The PCR products were purified using the ExoSAP cleanup procedure (Amersham Biosciences, France). All nucleotide sequences were obtained using the Big Dye Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and the 3130 automated sequencer (Applied Biosystems, Foster City, CA, USA). Sequences were edited and aligned using DNA Baser Sequence Aligner v3.5.4 software (Heracle BioSoft SRL, www.DnaBaser.com) to obtain optimal sequence alignment files. A BLAST analysis at the NCBI database was made to retrieve sets of homologues exhibiting high scores to the L gene of TOSV.
To build phylogenetic tree, the maximum parsimony [26 (link)] method calculating bootstrap confidence values of 100 bootstrapping trials, using the MEGA 5.2 software, was used.
+ Open protocol
+ Expand
3

Sequence Verification of Anaplasma spp. PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specificity of the duplex PCR was confirmed by sequencing PCR amplicons of A. marginale and A. phagocytophilum using primers M4-OvMar-F/M4-Mar-R for msp4 gene and Msp2-3 F/Msp2-3R for msp2, respectively. Thirteen randomly chosen positive PCR products were purified using the ExoSAP cleanup procedure (Amersham Biosciences, Piscataway, NJ, USA). All nucleotide sequences were obtained using the Big Dye Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) and the 3130 automated sequencer (Applied Biosystems). The sequences were edited and aligned using DNA Baser Sequence Aligner v3.5.4 software (Heracle BioSoft SRL, www.DnaBaser.com) to obtain optimal sequence alignment files. A BLAST analysis was made in the NCBI database to retrieve sets of homologues exhibiting high scores with the partial msp2 and msp4 gene of A. phagocytophilum and A. marginale, respectively.
+ Open protocol
+ Expand
4

Amplification and Sequencing of α-Globin Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two sets of primer pairs were designated and used to amplify and sequence the α‐globin gene (α1and α2) as shown in Table 1. The amplification was performed using 50 ng of genomic DNA, and 20 pmol of forward and reverse primers, on PCR machine (C‐1000, Bio‐Rad). The 47 μL PCR reaction mixture contained 5.0 μL of 10 × LA Buffer (TaKaRa), 4.0 μL of 2.5 mmol/L dNTPs, 2.0 μL of 10 pmol/L forward and reverse primers, 5.0 μL of 5 mol/L Betaine, 2.5 μL of DMSO, 0.5 μL of 5 μL LA Taq enzyme, 2 μL of DNA, and 24 μL of DNA‐free H2O. A total of 32 PCR cycles after initial heating at 95°C for 5 minutes were performed under the following PCR condition: 97°C for 45 seconds, 66°C for 30 seconds, and 72°C for 2 minutes and a final extension at 72°C for 10 minutes. The PCR products were sequenced by the 3130 automated sequencer (Applied Biosystems).
+ Open protocol
+ Expand
5

AHI1 Gene Exon Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exons and intron–exon boundaries of AHI1 were sequenced in one proband using 3130 Automated Sequencer (Applied Biosystems, Foster City, CA, USA). We used a touchdown protocol for the polymerase chain reaction (PCR) procedures to amplify all exons in the same conditions. Primer sequences and PCR conditions are available on request.
+ Open protocol
+ Expand
6

Filling Gaps in AvCoV Genome

Check if the same lab product or an alternative is used in the 5 most similar protocols
All primers used in the following procedures are available on request from the authors.
Endpoint RT-PCR and Sanger sequencing were employed to complete two short regions (each approximately 20 nt) of sequence in ORF 1b that remained undetermined by NGS. First, cDNA molecules corresponding to the regions of missing sequence were prepared using Superscript II (Invitrogen) according to the manufacturer's recommendations. Next, dsDNA PCR products were amplified from each cDNA using Expand High Fidelity enzyme (Roche) according to the manufacturer's recommendations. Finally PCR products were purified using a NucleoSpin Gel and PCR Clean-up kit (Macherey Nagel) and sequenced using a BigDye Terminator v3.1 Cycle Sequencing kit as recommended by the manufacturer, in a 3130 automated sequencer (Applied Biosystems). Each PCR product was amplified twice and sequenced in both directions. The genome 3′ extremity was determined using classic 3′ RACE as previously described (Sambrook & Russell, 2001 ). Several attempts to determine the 5′ extremity using 5′ RACE failed; therefore, a consensus sequence derived from the 5′ extremities of 68 other AvCoVs was added.
+ Open protocol
+ Expand
7

Calpain 3 Mutation Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mutations in Calpain 3 (CAPN3) were screened by direct sequencing using primer pairs for the 24 coding CAPN3 exons. All exons were amplified by PCR using Hotstart Taq polymerase (Qiagen). Oligonucleotides sequences and amplification conditions are available on request. PCR products were digested with ExoSAP-IT (GE Healthcare, Chalfont St Giles, UK) and sequenced using the BigDye Terminator Cycle Sequencing kit (Applied Biosystems). Amplicons were analyzed by capillary electrophoresis on an automated sequencer 3130 (Applied Biosystems) and the obtained DNA sequences were manually compared with wild type gene sequences.
+ Open protocol
+ Expand
8

CAPN3 Gene Mutation Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mutations in CAPN3 were screened through direct sequencing by using primer pairs for the 24 coding CAPN3 exons, GCF_000001405.25_GRCh37.p13 (19 April 2017). All exons were amplified with PCR by using a hot start Taq polymerase (Qiagen). PCR products were sequenced by using the BigDye Terminator Cycle Sequencing kit (Applied Biosystems). Amplicons were analyzed with capillary electrophoresis on an automated sequencer 3130 (Applied Biosystems), and the obtained DNA sequences were manually compared with wild type gene sequences.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!